Vicarious Surgical Inc (NYSE:RBOT – Get Free Report) saw a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 86,200 shares, a drop of 19.3% from the September 15th total of 106,800 shares. Based on an average daily trading volume, of 24,100 shares, the days-to-cover ratio is currently 3.6 days.
Vicarious Surgical Trading Up 1.4 %
RBOT opened at $6.41 on Monday. The stock has a fifty day moving average price of $5.98 and a 200 day moving average price of $7.70. Vicarious Surgical has a 1 year low of $4.27 and a 1 year high of $21.43. The stock has a market cap of $37.82 million, a price-to-earnings ratio of -0.62 and a beta of 1.12.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last announced its quarterly earnings results on Monday, August 12th. The company reported ($2.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.98) by $0.12. As a group, sell-side analysts forecast that Vicarious Surgical will post -10.07 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Vicarious Surgical
About Vicarious Surgical
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Further Reading
- Five stocks we like better than Vicarious Surgical
- Investing in Construction Stocks
- JPMorgan Can Hit New Highs This Year: Here’s Why
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Best Pharma Stocks for Long-Term Investors: Growth and Dividends
- Dividend Payout Ratio Calculator
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.